Background: Lower extremity venous thrombosis (LEVT) is the most frequent form of vascular involvement in Behcet's disease. Up to 17% of the mortality in Behcet's disease is reported to be associated with venous involvement such as pulmonary embolism or Budd-Chiari syndrome (BCS). Early recognition and appropriate management of vascular involvement in BD is essential to reduce associated morbidity and mortality. Homocysteine (hcy) may play a role in BD patient with venous affection. Objectives: To find out the role of homocysteine and venous Doppler ultrasonography in detection of venous insufficiency (VI) in BD patients. Subjects and Methods: A case control study, 50 patients with Behcet's diseaseand 50 age and sex matched healthy controls were included. Serum homocysteine (by ng/l) was determined by ELISA. Also measurement of VI by venous Doppler ultrasonography in lower limbs of Behcet's patients and controls. Results: In this study there was statistically significant difference between serum homocysteine level among BD patients and controls (p < 0.05). There was a significant difference between serum homocystiene levels in BD patients with venous versus non venous affections, p<0.05. There was a significal positive correlation between serum hcy levels and VI grades by Doppler US. Conclusions: Behcet's disease patients with hyperhomocysteinaemia and VI diagnosed by Power Doppler US should be considered as a strong indicator of pathological venous involvement.
INTRODUCTION
ehcet's disease (BD) is a systemic inflammatory vasculitis of unknown etiology, which presents with recurrent orogenital ulceration, uveitis, and erythema nodosum.
Other involvement may characterize the course of the disease: articular, vascular, central nervous system, and gastrointestinal involvements [1] .
Behcet's disease is more prevalent in the Mediterranean countries such as Turkey, Iran and Far East including Korea and Japan where the prevalence of HLA B 51 is higher than the general population. [2] .
Thrombotic events have been reported in ≈ 10-40% of patients with BD. Vascular lesions consist of venous and arterial thrombosis and various types of arterial aneurysms. Although involvement of all types and sizes of blood vessels may occur, in the lower extremity venous thrombosis predominates. Endothelial injury due to vascular inflammation is considered to be an important factor of thrombosis [3] .
Homocysteine (hcy) is a sulfur-containing amino acid produced during the metabolism of the essential amino acid methionine in all cells through the normal methylation process. Its sulphydryl group can cause direct endothelial cytotoxicity, inhibition of glutathione peroxidase and nitric oxide, interference with clotting factor, and oxidation of LDL. [4] Hyperhomocysteinaemia (Hhcy)  may  cause  lipid  peroxidation,  impaired  vasomotor regulation and prothrombotic  surface,  therefore  lead  to  vascular  endothelial injury and atherothrombogenesis [4] [5] .Some studies have shown an association between Hcy levels and endothelial dysfunction in patients with BD [5] .
Doppler ultrasound (US) is an important modality for the evaluation of vascular pathology to provide flow information in addition to vascular morphology. The most important advantages are that it is technically easily applicable, cheap and non-invasive [6] .
Some studies suggest a high prevalence of venous insufficiency (VI) and some cases of asymptomatic thrombosis in patients with BD [6] [7] . Early recognition and appropriate management of vascular involvement in BD is essential to reduce associated morbidity and mortality. [8] [9] .
In this study we aimed to assess the role of serum homocysteine and venous Doppler Ultrasonography in detection of venous insufficiency (VI) in BD patients.
SUBJECTS AND METHODS This case control study included 50 patients with Behcet's disease and 50 apparent healthy subjects as control group. BD patients were randomly selected from Rheumatology and Rehabilitation Department, Zagazig University Hospitals, between August 2014 and July 2017. All patients fulfilled the revised international criteria of Behcet disease (ICBD 2010) [10] . Exclusion criteria included patients with autoimmune diseases. Seronegative spondyloarthropathies, renal failure, cardiovascular diseases, liver diseases, cancers, diabetes mellitus and malnutrition. Hyperlipidemic disorders as in alcohol consumption, obesity, oral contraceptives, metabolic syndrome or hypothyroidism. Blood diseases as leukemia, lymphoma and idiopathic thrombocytopenic purpura and old age >60 years were excluded. Written and verbal consent was taken from all subjects.
All patients were subjected to full history taking, general and locomotor examination. Routine laboratory investigations including CBC, ESR, CRP, liver function test, kidney function test and Lipid profile were done.
Assessment of homocysteine levels in serum samples by specific sandwich enzymelinked immunosorbent assay (ELISA) kit supplied by Sun Red Company. The kit uses a double-antibody sandwich enzyme-linked immunosorbent assay (ELISA) to assay the level of Human Homocysteine (HCY) in samples.
Venous Doppler Ultrasonography:
This study was performed with 6.2 to 11 MHz linear multiband probe. All patients were evaluated by a single radiology doctor. Venous vessels of each side at the lower extremities were examined while the subjects were in supine position.
Almost all veins of both lower limbs (the common femoral vein, femoral vein, popliteal vein, anterior tibial vein, posterior tibial vein, and long saphenous vein and short saphenous vein) were examined by Doppler ultrasonography for detection of venous insufficiency.
When venous insufficiency was identified by Doppler US, a venous insufficiency (VI) grading system was used (CEAP)severity score [7] There was a significant difference between serum homocystiene levels in BD patients with and without venous affections, (p<0.05). 2 (4) 0 0 0 The most frequent Doppler US CEAP grading was (grade 1) 42% and the least frequent was ( grade 4) 6% in BD patients group while among controls 4% were (grade 1) who were obese but without dyslipidemia, diabetes or hypertension. There was a highly significant difference between both groups, p<0.001. There was a highly significant relation between serum homocystiene levels and grades of VI By Doppler US in BD patients, p< 0.001. There was a highly statistically significance and strong positive correlation between serum hcy and VI by Doppler US using CEAP severity grades. Table ( The most frequent used medication among BD patients in this study was corticosteroids (76%) followed by colchicine and azathioprine (62%) and (50%) respectively while least used medication was cholarambucil (4%). DISCUSSION This research aimed to investigate the relation between serum homocysteine level and vascular affection in BD patients. Also the role of venous Doppler US for both lower limbs veins of BD patients in detection of venous insufficiency. In this study there was a statistically significant difference between serum homocysteine level in BD patients and controls (p < 0.05). That was nearly similar to results of Ozdemir et al. [12] and Wu Y-H, et al. [13] who found a statistically significant difference of s. Hcy levels between patients versus control (p <0.001).
Our study showed a significant difference between serum homocystiene levels in BD patients with venous versus non venous affections, p<0.05. Bahsi et al. [14] , Ates et al. [15] , Shahram et al. [16] , La Regina et al. [5] and Durmazlar et al. [17] also confirmed our results that serum homocysteine was significally higher in vascular affection in BD patients in comparison with patients without vascular involvement. Although Shadmanfar etal. [18] and Senturk et al.s [19] found that there was no statistical difference in hcy levels between BD patients with and without thrombosis These results may be explained by that the vascular thrombosis in BD is accepted to be the result of the inflammation of the vessel wall. Hcy generates superoxide and hydrogen peroxide, both of which have been linked to endothelial damage [20] .Hcy-induced vascular problems are thought to be multifactorial, including direct Hcy damage to the endothelium, enhanced lipid peroxidation and increased platelet aggregation by the effects on the coagulation system [17] . . In our study there was no significant correlation between serum homocysteine level and CRP (r =0.19, p>0.05) that was in agreement to the study of Allam et al. [20] , on contrary, Ozdemir et al. found a significant correlation between serum homocysteine level and CRP (r =0.45, P<0.05).
In our study there was no significant correlation between serum homocysteine level and ESR (r =0.16, p> 0.05) that was in accordance to the study of Shahram et al. [16] .
US CEAP severity score was used to evaluate the severity of the venous insufficiency by venous Doppler ultrasonography (US) in lower extremities, In our study venous insufficiency findings were detected in 36 of 50 patients (72%) in the BD group but 2 out of 50 (4%) in the healthy control group. Kisacik et al. [7] found nearly In the current study, Behcet disease group had a significantly higher US CEAP severity scores than healthy controls, P <0.001, these results are in agreement with Kisacik et al. [7] and Alibaz-Oner et al. [6] .
In present study it was found that among BD patients the most frequent Doppler US CEAP grading of VI was (grade 1) 42% Minimal incompetence ( valve reflux exists beyond the uppermost valve in the femoral vein, but not beyond the proximal aspect of the thigh) and the least frequent was( grade 4) 6% Severe incompetence ( valve reflux occurs into the pair calf veins to the level of the ankle) these results could be attributed to the corticosteroid and immunosuppressive medications received by most of the studied patients for vascular BD manifestations and their role in suppressing venous wall inflammation and hence thrombosis.
The results of the present study are in accordance with the study of Desbois et al. [22] which deduced that immunosuppressive agents improve prognosis by decreasing the odds of venous thrombosis relapse in BD. Also Seyahi (23) concluded that immunosuppressive medications are essential in preventing the attacks and increasing survival of vascular involvement in BD.
The relationship between inflammation and venous thrombosis has recently been highlighted. Inflammation may lead to venous thrombosis by inhibiting both anti-coagulant pathway and fibrinolytic activity. Also endothelial damage and dysfunction have been incriminated in pathogenesis of VI in BD [21] . Desbois et al. [22] assessed factors associated with thrombosis relapse and mortality. They mentioned that the use of immunosuppressive drugs was found to prevent relapse of venous thrombosis and there was a trend towards prevention of relapse with the use of steroids.
In current study there was a highly significant relation between serum homocystiene levels and grades of Doppler US CEAP score in BD patients, (p<0.001). Also there was a statistically significant difference and strong positive correlation between plasma hcy and CEAP grades of VI by Doppler US ( r= 0.8 ), To our currently knowledge there is no similar studies.
In this study the commonly used drugs in our patients was corticosteriods ,colchicine and azathioprine. Nearly similar results were recorded by Gheita et al. [24] where the most commonly used drugs were corticosteroids , colchicine and azathioprine . Conclusions: Hyperhomocysteinaemia might be an independent risk factor for venous insufficiency in BD. As a non-invasive method, Doppler Ultrasonographic screening of lower extremities may detect early venous insufficiency in BD even in patients without symptomatic or history of thrombosis.Behcet disease patients with both hyperhomocysteinaemia and VI diagnosed by Power Doppler US should be considered as a strong indicator of pathological venous involvement.
